Immunotherapy: Treatment-Related Issues

Brianna Hoffner, MSN, ANP-BC, AOCNP®
University of Colorado Cancer Center

Posted: 6/28/2018
Expires: 6/28/2019
Estimated time to complete: 45 minutes

This activity is supported by independent educational grants from AstraZeneca and Bristol-Myers Squibb.

Instructions for Earning CE credit

This activity has expired, credit is no longer available.


Quick Tips

What is the rationale for sequencing and combining immunotherapy with chemotherapy?
How useful is biomarker testing in choosing patients for immunotherapy?
What combination therapies lead to more durable responses?
How do we understand response patterns in immunotherapy?
Copyright © 2010-2021 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.